You are here

obesity

Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns

CBS News

Thu, 05/15/25 - 10:47 am

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Fierce Biotech

Wed, 05/14/25 - 10:56 am

Roche plans $700m manufacturing plant in the US

Yahoo Finance

Mon, 05/12/25 - 09:49 pm

drug manufacturing

Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill

BioSpace

Mon, 05/5/25 - 11:29 am

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

FDA frees Amgen's phase 1 obesity asset from clinical trial hold

Fierce Biotech

Fri, 05/2/25 - 11:18 am

clinical trials

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans

CNBC

Thu, 05/1/25 - 11:10 am

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool

Wed, 04/30/25 - 11:00 am

Viking Therapeutics

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%

CNBC

Tue, 04/29/25 - 08:23 am

Hims & Hers Health

Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity

MSN/Reuters

Wed, 04/23/25 - 10:27 pm

Novo says it’s submitted obesity pill for FDA approval

BioPharma Dive

Mon, 04/21/25 - 06:13 pm

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts

Fierce Pharma

Thu, 04/17/25 - 11:06 pm

BMO Capital Markets

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Yahoo/Bloomberg

Thu, 04/17/25 - 11:34 am

clinical trials

Why Pfizer Stock Topped the Market on Tuesday

Motley Fool

Tue, 04/15/25 - 07:53 pm

clinical trials

Pfizer axes oral GLP-1 asset over liver injury, blowing hole in obesity plan

Fierce Biotech

Mon, 04/14/25 - 11:03 am

clinical trials

This Pharma Company Is Betting Big On A Chinese Ozempic Rival

Forbes

Sun, 04/13/25 - 11:13 pm

Kailera Therapuetics

HHS leaves door open to future Medicare coverage of obesity drugs

BioSpace

Tue, 04/8/25 - 11:54 am

Rhythm Drug Leads to Reduced BMI in Rare Obesity Indication

BioSpace

Mon, 04/7/25 - 11:16 am

Rhythm Pharmaceuticals

clinical trials

hypothalamic obesity

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC

Sun, 04/6/25 - 11:40 pm

Pages